Search

Your search keyword '"Hovius JW"' showing total 815 results

Search Constraints

Start Over You searched for: "Hovius JW" Remove constraint "Hovius JW" Language english Remove constraint Language: english
815 results on '"Hovius JW"'

Search Results

1. Limited evidence of infection with other tick-borne pathogens in patients tested for Lyme neuroborreliosis in the Netherlands.

2. Exposure, infection and disease with the tick-borne pathogen Borrelia miyamotoi in the Netherlands and Sweden, 2007-2019.

3. Bridging the gap: Insights in the immunopathology of Lyme borreliosis.

5. Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands.

6. Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification.

7. Combining short- and long-read sequencing unveils geographically structured diversity in Borrelia miyamotoi .

8. Review of literature and clinical practice experience for the therapeutic management of Morgellons disease.

9. A comprehensive genetic map of cytokine responses in Lyme borreliosis.

10. Development of a sequence-based in silico OspA typing method for Borrelia burgdorferi sensu lato .

11. Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires.

12. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications.

13. Tick-borne diseases in the North Sea region-A comprehensive overview and recommendations for diagnostics and treatment.

14. Clinical manifestations of Lyme neuroborreliosis in children: a review.

15. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.

16. Age-related changes in plasma biomarkers and their association with mortality in COVID-19.

17. Mapping the human genetic architecture of COVID-19

18. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

19. Detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid samples following pre-enrichment culture.

20. Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.

21. Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].

22. Acute facial nerve palsy in children in a Lyme disease-endemic area in the Netherlands.

23. Persistent Borrelia burgdorferi Sensu Lato Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models.

24. Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi.

25. Digital disparities among healthcare workers in typing speed between generations, genders, and medical specialties: cross sectional study.

26. Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.

27. CD55 Facilitates Immune Evasion by Borrelia crocidurae, an Agent of Relapsing Fever.

28. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.

29. Prevalence and clinical manifestation of Borrelia miyamotoi in Ixodes ticks and humans in the northern hemisphere: a systematic review and meta-analysis.

30. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.

31. Knowing the entire story - a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease).

32. An intervention in general practice to improve the management of Lyme borreliosis in Denmark.

34. Self-reported symptoms and health complaints associated with exposure to Ixodes ricinus-borne pathogens.

35. Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.

36. No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium.

37. Opinion: Methodological Shortcomings in the Study on a Prophage-based PCR Test for Lyme Borreliosis.

39. Are other tick-borne infections overlooked in patients investigated for Lyme neuroborreliosis? A large retrospective study from South-eastern Sweden.

40. Probing an Ixodes ricinus salivary gland yeast surface display with tick-exposed human sera to identify novel candidates for an anti-tick vaccine.

41. Primary cutaneous melioidosis acquired in Nepal - Case report and literature review.

42. Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study.

43. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

44. Diagnostic Performance of the Novel BioPlex Lyme Serological Assays in European Patients with Lyme Disease.

45. Identification and Characterization of Immunodominant Proteins from Tick Tissue Extracts Inducing a Protective Immune Response against Ixodes ricinus in Cattle.

46. Ticking on Pandora's box: a prospective case-control study into 'other' tick-borne diseases.

47. Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.

48. Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.

49. Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement.

50. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.

Catalog

Books, media, physical & digital resources